Heier Jeffrey S. 4
4 · OCULAR THERAPEUTIX, INC · Filed Oct 18, 2022
Insider Transaction Report
Form 4
Heier Jeffrey S.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-10-17+16,000→ 16,000 totalExercise: $4.25Exp: 2032-10-16→ Common Stock (16,000 underlying)
Footnotes (1)
- [F1]Vests over four years, with 1/48 of the shares underlying the option vesting monthly beginning on August 1, 2022.